BioCentury
ARTICLE | Company News

Peptech, Diversys research deal

April 5, 2001 7:00 AM UTC

Diversys ( Cambridge, U.K.) will develop single domain antibody drug candidates against four Peptech targets. Peptech (ASX:PTD) will pay Diversys a guaranteed $10 million in cash and invest $7 million...